Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Shapiro

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1994
Late cardiac effects of adjuvant therapy: too soon to tell?C L Shapiro, I C Henderson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1992
Radiation-associated breast cancer after Hodgkin's disease: risks and screening in perspectiveC L Shapiro, P M Mauch
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancerC L Shapiro, J Manola, M Leboff
Seminars in Oncology|April 1, 1995
Treatment of metastatic breast cancer: present and future prospectsD F Hayes, I C Henderson, C L Shapiro
Analytical Biochemistry|January 1, 1981
An assay for activity of arogenate dehydratase base upon the selective oxidation of arogenateC L Shapiro, R A Jensen, K A Wilson, et al.
Molecular and Cellular Biology|May 1, 1981
The aromatic amino acid pathway branches at L-arogenate in Euglena gracilisG S Byng, R J Whitaker, C L Shapiro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 26, 2005
Phase I trial of liposomal encapsulated doxorubicin (Myocet; D-99) and weekly docetaxel in advanced breast cancer patientsE Mrózek, C A Rhoades, J Allen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Phase II trial of high-dose liposome-encapsulated doxorubicin with granulocyte colony-stimulating factor in metastatic breast cancer. TLC D-99 Study GroupC L Shapiro, T Ervin, L Welles, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 15, 2008
Phase II study of sequentially administered low-dose mitomycin-C (MMC) and irinotecan (CPT-11) in women with metastatic breast cancer (MBC)E Mrozek, J Kolesar, D Young, et al.
Cancer|January 10, 2001
Prognostic significance of the number of bone scan abnormalities at the time of initial bone metastatic recurrence in breast carcinomaA F Jacobson, C L Shapiro, A D Van den Abbeele, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1994
Late cardiac effects of adjuvant therapy: too soon to tell?C L Shapiro, I C Henderson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1992
Radiation-associated breast cancer after Hodgkin's disease: risks and screening in perspectiveC L Shapiro, P M Mauch
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancerC L Shapiro, J Manola, M Leboff
Seminars in Oncology|April 1, 1995
Treatment of metastatic breast cancer: present and future prospectsD F Hayes, I C Henderson, C L Shapiro
Analytical Biochemistry|January 1, 1981
An assay for activity of arogenate dehydratase base upon the selective oxidation of arogenateC L Shapiro, R A Jensen, K A Wilson, et al.
Molecular and Cellular Biology|May 1, 1981
The aromatic amino acid pathway branches at L-arogenate in Euglena gracilisG S Byng, R J Whitaker, C L Shapiro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 26, 2005
Phase I trial of liposomal encapsulated doxorubicin (Myocet; D-99) and weekly docetaxel in advanced breast cancer patientsE Mrózek, C A Rhoades, J Allen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Phase II trial of high-dose liposome-encapsulated doxorubicin with granulocyte colony-stimulating factor in metastatic breast cancer. TLC D-99 Study GroupC L Shapiro, T Ervin, L Welles, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 15, 2008
Phase II study of sequentially administered low-dose mitomycin-C (MMC) and irinotecan (CPT-11) in women with metastatic breast cancer (MBC)E Mrozek, J Kolesar, D Young, et al.
Cancer|January 10, 2001
Prognostic significance of the number of bone scan abnormalities at the time of initial bone metastatic recurrence in breast carcinomaA F Jacobson, C L Shapiro, A D Van den Abbeele, et al.
Pageof 4